Depreciation of Apogee Therapeutics, Inc. from 31 Mar 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Apogee Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2024 to 31 Dec 2025.
  • Apogee Therapeutics, Inc. Depreciation for the quarter ending 31 Dec 2025 was $411,000.
  • Apogee Therapeutics, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $1,418,000.
  • Apogee Therapeutics, Inc. annual Depreciation for 2025 was $1,418,000, a 650% increase from 2024.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Apogee Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,418,000 $411,000 01 Oct 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $400,000 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $400,000 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $207,000 +$178,000 +614% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $29,000 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Apogee Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,418,000 +$1,229,000 +650% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $189,000 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.